Characterisation of Fractionated Electrograms Critical for Maintenance of Atrial Fibrillation (AF)

The purpose of this study is to characterise which fractionated electrogram morphologies are important to target in the catheter ablation of atrial fibrillation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Barts and The London NHS Trust

London, EC1 A7BE, United Kingdom

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients with persistent AF listed for first time catheter ablation

Exclusion criteria

age < 18 years
pregnancy
contraindications to procedure
recent myocardial infarction, coronary intervention, or cardiac surgery

Treatment and study plan

Catheter ablation

Procedure

catheter ablation using radiofrequency energy

Primary outcomes

change in AF cycle length when targeting fractionated electrograms of different morphology.

Time frame: immediate

Sponsors and collaborators

Lead sponsor

Barts & The London NHS Trust

Other

Registry information

Official study title

Characterisation of Fractionated Electrograms Critical for Maintenance of AF

Acronym: CAFE AF

Important dates

Study start: 2009
Primary completion: 2011
Study completion: 2011
First posted: May 7, 2009
Registry last updated: Aug 2, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed